Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model

Neuroscience

Volumn 248, Issue , 2013, Pages 333-343

  Marconi, S ^a   Bonaconsa, M ^a   Scambi, I ^a   Squintani, G M ^b   Rui, W ^a   Turano, E ^a   Ungaro, D ^c   D'Agostino, S ^a   Barbieri, F ^a   Angiari, S ^a   Farinazzo, A ^a   Constantin, G ^a   Del Carro, U ^c   Bonetti, B ^a   Mariotti, R ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Amyotrophic lateral sclerosis; GDNF; Motorneuron disease; Neurotrophins

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; NEUROPROTECTIVE AGENT; SUPEROXIDE DISMUTASE;

ADIPOSE DERIVED MESENCHYMAL STEM CELL; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; CONTROLLED STUDY; DETERIORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTONEURON; MOTOR PERFORMANCE; MOUSE; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; CYTOLOGY; DISEASE MODEL; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MOTOR ACTIVITY; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

ADIPOSITY; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MOTOR NEURONS; NEUROPROTECTIVE AGENTS; SPINAL CORD; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; UP-REGULATION;

EID: 84880612494     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.05.034     Document Type: Article

References (49)

1. Anghileri E., Marconi S., Pignatelli A., Cifelli P., Galie M., Sbarbati A., Krampera M., Belluzzi O., Bonetti B. Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. Stem Cells Dev 2008, 17:909-916.
2. Bendotti C., Carri M.T. Lessons from models of SOD1-linked familial ALS. Trends Mol Med 2004, 10:393-400.
3. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006, 98:1076-1084.
4. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001, 2:806-819.
5. Constantin G., Marconi S., Rossi B., Angiari S., Calderan L., Anghileri E., Gini B., Bach S.D., Martinello M., Bifari F., et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009, 27:2624-2635.
6. Corti S., Locatelli F., Donadoni C., Guglieri M., Papadimitriou D., Strazzer S., Del Bo R., Comi G.P. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004, 127:2518-2532.
7. Corti S., Nizzardo M., Nardini M., Donadoni C., Salani S., Simone C., Falcone M., Riboldi G., Govoni A., Bresolin N., Comi G.P. Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Hum Mol Genet 2010, 19:3782-3796.
8. De Ugarte D.A., Alfonso Z., Zuk P.A., Elbarbary A., Zhu M., Ashjian P., Benhaim P., Hedrick M.H., Fraser J.K. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett 2003, 89:267-270.
9. Ekestern E. Neurotrophic factors and amyotrophic lateral sclerosis. Neurodegener Dis 2004, 1:88-100.
10. 2. Glia 2011, 59:1719-1731.
11. Garbuzova-Davis S., Willing A.E., Saporta S., Justen E.B., Misiuta I.E., Dellis J., Sanberg P.R. Multiple transplants of hNT cells into the spinal cord of SOD1 mouse model of familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2006, 7:221-226.
12. Garbuzova-Davis S., Sanberg C.D., Kuzmin-Nichols N., Willing A.E., Gemma C., Bickford P.C., Miller C., Rossi R., Sanberg P.R. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS One 2008, 3:e2494.
13. Garbuzova-Davis S., Rodrigues M.C., Mirtyl S., Turner S., Mitha S., Sodhi J., Suthakaran S., Eve D.J., Sanberg C.D., Kuzmin-Nichols N., Sanberg P.R. Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS. PLoS One 2012, 7:e31254.
14. Gould T.W., Oppenheim R.W. Motor neuron trophic factors: therapeutic use in ALS?. Brain Res Rev 2011, 67:1-39.
15. Gu R., Hou X., Pang R., Li L., Chen F., Geng J., Xu Y., Zhang C. Human adipose-derived stem cells enhance the glutamate uptake function of GLT1 in SOD1(G93A)-bearing astrocytes. Biochem Biophys Res Commun 2010, 393:481-486.
16. Gundersen H.J. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J Microsc 1986, 143:3-45.
17. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
18. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simmons L., Moffet B., Vandlen R.A., Simpson L.C., et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994, 266:1062-1064.
19. Henriques A., Pitzer C., Schneider A. Characterization of a novel SOD-1(G93A) transgenic mouse line with very decelerated disease development. PLoS One 2010, 5:e15445.
20. Hipp J., Atala A. Sources of stem cells for regenerative medicine. Stem Cell Rev 2008, 4:3-11.
21. Huang H., Chen L., Sanberg P. Cell therapy from bench to bedside translation in CNS neurorestoratology era. Cell Med 2010, 1:15-46.
22. Kaspar B.K. Mesenchymal stem cells as trojan horses for GDNF delivery in ALS. Mol Ther 2008, 16:1905-1906.
23. Kassa R.M., Bentivoglio M., Mariotti R. Changes in the expression of P2X1 and P2X2 purinergic receptors in facial motoneurons after nerve lesions in rodents and correlation with motoneuron degeneration. Neurobiol Dis 2007, 25:121-133.
24. Kassa R.M., Mariotti R., Bonaconsa M., Bertini G., Bentivoglio M. Gene, cell, and axon changes in the familial amyotrophic lateral sclerosis mouse sensorimotor cortex. J Neuropathol Exp Neurol 2009, 68:59-72.
25. Kato S. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol 2008, 115:97-114.
26. Kern S., Eichler H., Stoeve J., Kluter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
27. Knippenberg S., Thau N., Schwabe K., Dengler R., Schambach A., Hass R., Petri S. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 2012, 9:107-120.
28. Krampera M., Marconi S., Pasini A., Galie M., Rigotti G., Mosna F., Tinelli M., Lovato L., Anghileri E., Andreini A., et al. Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone 2007, 40:382-390.
29. Li W., Brakefield D., Pan Y., Hunter D., Myckatyn T.M., Parsadanian A. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp Neurol 2007, 203:457-471.
30. Lin G., Garcia M., Ning H., Banie L., Guo Y.L., Lue T.F., Lin C.S. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 2008, 17:1053-1063.
31. Marconi S., Castiglione G., Turano E., Bissolotti G., Angiari S., Farinazzo A., Constantin G., Bedogni G., Bedogni A., Bonetti B. Human adipose-derived mesenchymal stem cells systemically injected promote peripheral nerve regeneration in the mouse model of sciatic crush. Tissue Eng Part A 2012, 18:1264-1272.
32. McIntosh K., Zvonic S., Garrett S., Mitchell J.B., Floyd Z.E., Hammill L., Kloster A., Di Halvorsen Y., Ting J.P., Storms R.W., et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 2006, 24:1246-1253.
33. Meyerrose T.E., De Ugarte D.A., Hofling A.A., Herrbrich P.E., Cordonnier T.D., Shultz L.D., Eagon J.C., Wirthlin L., Sands M.S., Hedrick M.A., Nolta J.A. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 2007, 25:220-227.
34. Miana-Mena F.J., Munoz M.J., Yague G., Mendez M., Moreno M., Ciriza J., Zaragoza P., Osta R. Optimal methods to characterize the G93A mouse model of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2005, 6:55-62.
35. Mitchell J.B., McIntosh K., Zvonic S., Garrett S., Floyd Z.E., Kloster A., Di Halvorsen Y., Storms R.W., Goh B., Kilroy G., et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006, 24:376-385.
36. Park S., Kim H.T., Yun S., Kim I.S., Lee J., Lee I.S., Park K.I. Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice. Exp Mol Med 2009, 41:487-500.
37. Puissant B., Barreau C., Bourin P., Clavel C., Corre J., Bousquet C., Taureau C., Cousin B., Abbal M., Laharrague P., et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005, 129:118-129.
38. Ruster B., Gottig S., Ludwig R.J., Bistrian R., Muller S., Seifried E., Gille J., Henschler R. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006, 108:3938-3944.
39. Sariola H., Saarma M. Novel functions and signalling pathways for GDNF. J Cell Sci 2003, 116:3855-3862.
40. Sejvar J.J., Holman R.C., Bresee J.S., Kochanek K.D., Schonberger L.B. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology 2005, 25:144-152.
41. Shen L.H., Li Y., Chopp M. Astrocytic endogenous glial cell derived neurotrophic factor production is enhanced by bone marrow stromal cell transplantation in the ischemic boundary zone after stroke in adult rats. Glia 2010, 58:1074-1081.
42. Suzuki M., McHugh J., Tork C., Shelley B., Hayes A., Bellantuono I., Aebischer P., Svendsen C.N. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 2008, 16:2002-2010.
43. Turner B.J., Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol 2008, 85:94-134.
44. Uccelli A., Milanese M., Principato M.C., Morando S., Bonifacino T., Vergani L., Giunti D., Voci A., Carminati E., Giribaldi F., et al. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis. Mol Med 2012, 18:794-804.
45. Vercelli A., Mereuta O.M., Garbossa D., Muraca G., Mareschi K., Rustichelli D., Ferrero I., Mazzini L., Madon E., Fagioli F. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2008, 31:395-405.
46. Wang L.J., Lu Y.Y., Muramatsu S., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Matsushita T., Hanazono Y., Kume A., et al. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci 2002, 22:6920-6928.
47. Weydt P., Hong S.Y., Kliot M., Moller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 2003, 14:1051-1054.
48. Xu L., Yan J., Chen D., Welsh A.M., Hazel T., Johe K., Hatfield G., Koliatsos V.E. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 2006, 82:865-875.
49. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P., Hedrick M.H. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.